tradingkey.logo
搜索

瑞思迈

RMD
添加自选
191.890USD
0.0000.00%
收盘 07-23 16:00美东报价延迟15分钟
27.83B总市值
18.43市盈率 TTM

关于 瑞思迈 公司

ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.

瑞思迈简介

公司代码RMD
公司名称Resmed Inc
上市日期Jun 01, 1995
CEOFarrell (Michael J)
员工数量10600
证券类型Ordinary Share
年结日Jun 01
公司地址9001 Spectrum Center Blvd
城市SAN DIEGO
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家United States of America
邮编92123
电话18587462400
网址https://www.resmed.com/
公司代码RMD
上市日期Jun 01, 1995
CEOFarrell (Michael J)

瑞思迈公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
Dr. Peter C. Farrell, Ph.D.
Dr. Peter C. Farrell, Ph.D.
Founder and Chairman Emeritus
Founder and Chairman Emeritus
--
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jan De Witte
Mr. Jan De Witte
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%

常见问题

瑞思迈的前五大股东是谁?

瑞思迈 的前五大股东如下:Mr. Michael J. (Mick) Farrell

有多少机构持有瑞思迈(RMD)的股份?

截至2026Q1,共有1873家机构持有瑞思迈的股份,合计持有的股份价值约为100.10M,占公司总股份的69.00%。与2025Q4相比,机构持股有所增加,增幅为-1407565.00。

哪个业务部门对瑞思迈的收入贡献最大?

在2026Q1,Devices业务部门对瑞思迈的收入贡献最大,创收726.21M,占总收入的51.04%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有